DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Wednesday 2 December 2015

Peter J. Skrdla

.
 
  • Department of Product Development
    London, United Kingdom

    ABOUT

    Pete received his Ph.D. degree in chemistry from the University of Arizona in 1999. He joined Merck (MSD) in the same year and worked there until 2014, at which time he took a position at GSK. He has extensive experience in drug development, working on/leading cross-functional teams, mentoring scientists and managing multiple projects/staff. He is interested in analytical R&D, particle engineering, physical pharmacy, nanotechnology and formulation approaches for poorly bio-available drugs.
     
    Links
https://www.linkedin.com/in/peter-j-skrdla-5b44a92
https://www.researchgate.net/profile/Peter_Skrdla/info
http://www.americanpharmaceuticalreview.com/1429-AuthorProfile/2020-Peter-J-Skrdla/
http://www.pubfacts.com/author/Peter+J+Skrdla


Peter J. Skrdla

Summary

Pete received his Ph.D. degree in chemistry from the University of Arizona in 1999. He joined Merck (MSD) in the same year and continued working there until 2014, progressing in his career from Senior Research Chemist to Principal Scientist. He has extensive experience in drug development, working on/leading cross-functional teams, mentoring other scientists and managing multiple projects/staff at the same time. He was directly involved in the commercialization of several Merck drugs, being responsible for both the technical and regulatory aspects of such.
In 2014, Pete joined GlaxoSmithKline (GSK) in the capacity of Team Leader, where he currently manages a group of scientists in the development of new pharmaceuticals (API and DP).
Pete's research interests include physical and chemical characterization, physical pharmacy, enabled formulations, nanotechnology, solid-state phase transformations, modeling, chromatography and thermal analysis (https://www.researchgate.net/profile/Peter_Skrdla/).

Education

University of Arizona

Ph.D., Chemistry
1995 – 1999

Experience

Team Leader

GSK
May 2014 – Present (1 year 8 months)Upper Providence, PA
Coordinates the activities of a group of scientists in support of the development of new medicines. Participates on cross-functional teams with the same mission.

Principal Scientist, ADC, MMD

Merck
April 2013 – March 2014 (1 year)Rahway, NJ
Technical Team Lead (TTL)

Principal Scientist, Preformulation, MRL

Merck
October 2012 – May 2013 (8 months)Summit, NJ
Preformulation scientist working on preparing and characterizing prototype formulations, enabled formulations (rotational opportunity)

Senior Investigator, MMD

Merck & Co., Inc.
January 2008 – August 2012 (4 years 8 months)Rahway, NJ
Analytical team leader, ADC

Principal Analytical Chemist, MMD

Merck
January 2007 – December 2007 (1 year)Rahway, NJ
Group leader, Analytical Development & Commercialization (ADC)

Research Fellow, MRL

Merck
August 2002 – December 2006 (4 years 5 months)Rahway, NJ
Group leader, Analytical Research (AR)

Senior Research Chemist, MRL

Merck & Co., Inc.
July 1999 – August 2002 (3 years 2 months)Rahway, NJ
Ph.D. scientist and project leader, Analytical Research (AR)

RESEARCH EXPERIENCE

  • Jul 1999–present
    Principal Investigator
    Merck · Analytical Chemistry and Development
    United States · Whitehouse Station
  • Sep 1995–Jul 1999
    Research/Teaching Assistant
    The University of Arizona · Department of Chemistry and Biochemistry (College of Science) · Saavedra and Armstrong
    United States · Tucson

AWARDS & ACHIEVEMENTS

  • Jan 2013
    Award: Merck Discovery Pharmaceutical Sciences Team Award
  • Aug 2012
    Award: Merck Technology Roadmap
  • May 2010
    Award: Merck Brinavess Launch Team
  • May 2007
    Award: Merck Emend-IV Launch Team
  • May 1997
    Scholarship: Graduate Mid-Career Fellowship



 


///////////

CPhI India, Dec2015, MUMBAI, INDIA.



 

With Dr Charlotte Wiles, CEO, CHEMTRIX BV , Cambridge, UK at CPhI India, Dec2015, MUMBAI, INDIA......At Pi-inc (Process Intensification Experts LLP) stall, hall 5 H47,


Meet her at.............. http://selectbiosciences.com/conferences/index.aspx?conf=FCINDIA16&se=india

Flow Chemistry India 2016

Date: Thursday, 21 January 2016 - Friday, 22 January 2016
Location: Mumbai



 


At Pi-inc (Process Intensification Experts LLP) stall, hall 5 H47, seen is Asif rangwala of ATR-ASAHI GLASS


 

At Pi-inc (Process Intensification Experts LLP) stall, hall 5 H47, seen is Mr Vijay Kirpalani with Charlotte wiles